Clinical trials
Recruiting Thrombocythemia, Essential trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hangzhou GluBio Pharmaceutical Co., Ltd. | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Xiamen Amoytop Biotech Co., Ltd. | 1 |
| Zhenya Hong | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocythemia, Essential | 4 |
| Leukemia, Myeloid, Acute | 2 |
| Myelodysplastic Syndromes | 2 |
| Polycythemia Vera | 2 |
| Anemia, Aplastic | 1 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Hemoglobinuria, Paroxysmal | 1 |
| Hemophilia A | 1 |
| Hemophilia B | 1 |
| Hemostatic Disorders | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.